| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.03 |